These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 22098155

  • 1. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.
    Noda T, Yamamoto H, Takemasa I, Yamada D, Uemura M, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H.
    Liver Int; 2012 Jan; 32(1):110-8. PubMed ID: 22098155
    [Abstract] [Full Text] [Related]

  • 2. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [Abstract] [Full Text] [Related]

  • 3. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S.
    Cancer; 2005 Jan 15; 103(2):307-12. PubMed ID: 15593087
    [Abstract] [Full Text] [Related]

  • 4. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.
    J Gastroenterol Hepatol; 2012 Jan 15; 27(1):173-80. PubMed ID: 21777276
    [Abstract] [Full Text] [Related]

  • 5. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J.
    Clin Cancer Res; 2009 Sep 01; 15(17):5518-27. PubMed ID: 19706825
    [Abstract] [Full Text] [Related]

  • 6. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T, Zhu Y, Qin CY, Yang Z, Fang A, Xu S, Ren W.
    J Clin Pathol; 2012 Sep 01; 65(9):808-14. PubMed ID: 22734007
    [Abstract] [Full Text] [Related]

  • 7. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T, Takahashi M, Nakagawa T, Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki M, Matsushita M, Furukawa H, Todo S.
    Ann Surg; 2006 Sep 01; 244(3):451-63. PubMed ID: 16926571
    [Abstract] [Full Text] [Related]

  • 8. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M.
    Ann Surg Oncol; 2008 May 01; 15(5):1375-82. PubMed ID: 18324443
    [Abstract] [Full Text] [Related]

  • 9. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, Changchien CS, Lee CM, Chuang JH, Tai MH.
    Cancer; 2003 Oct 01; 98(7):1444-56. PubMed ID: 14508832
    [Abstract] [Full Text] [Related]

  • 10. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR, Xu Y, Shi GM, Fan J, Zhou J, Ji Y, Sun HC, Qiu SJ, Yu B, Gao Q, He YZ, Qin WZ, Chen RX, Yang GH, Wu B, Lu Q, Wu ZQ, Tang ZY.
    Clin Cancer Res; 2008 Jun 15; 14(12):3850-9. PubMed ID: 18559605
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
    Ng KT, Qi X, Kong KL, Cheung BY, Lo CM, Poon RT, Fan ST, Man K.
    Eur J Cancer; 2011 Oct 15; 47(15):2299-305. PubMed ID: 21683576
    [Abstract] [Full Text] [Related]

  • 12. Importin-α1 as a novel prognostic target for hepatocellular carcinoma.
    Yoshitake K, Tanaka S, Mogushi K, Aihara A, Murakata A, Matsumura S, Mitsunori Y, Yasen M, Ban D, Noguchi N, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S.
    Ann Surg Oncol; 2011 Jul 15; 18(7):2093-103. PubMed ID: 21286940
    [Abstract] [Full Text] [Related]

  • 13. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H, Nagano H, Yamamoto H, Yang Y, Kondo M, Ota H, Nakamura M, Yoshioka S, Kato H, Damdinsuren B, Tang D, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Sakon M, Dono K, Wakasa K, Monden M.
    Liver Int; 2006 May 15; 26(4):414-23. PubMed ID: 16629644
    [Abstract] [Full Text] [Related]

  • 14. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T, Aishima S, Umeda K, Sanefuji K, Fujita N, Sugimachi K, Gion T, Taketomi A, Maehara Y, Tsuneyoshi M.
    J Surg Oncol; 2009 Dec 01; 100(7):575-9. PubMed ID: 19697358
    [Abstract] [Full Text] [Related]

  • 15. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI, Kim JM, Jung GO, Chun JM, Choi GS, Park JB, Kwon CH, Kim SJ, Jo JW.
    Korean J Hepatol; 2008 Jun 01; 14(2):185-96. PubMed ID: 18617766
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
    Nanashima A, Yano H, Yamaguchi H, Tanaka K, Shibasaki S, Sumida Y, Sawai T, Shindou H, Nakagoe T.
    J Gastroenterol; 2004 Jun 01; 39(2):148-54. PubMed ID: 15069621
    [Abstract] [Full Text] [Related]

  • 17. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R, Cui J, Xu C, Xue T, Guo K, Gao D, Liu Y, Ye S, Ren Z.
    Ann Surg Oncol; 2012 Jul 01; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [Abstract] [Full Text] [Related]

  • 18. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, Oka M.
    Int J Oncol; 2008 Oct 01; 33(4):725-31. PubMed ID: 18813785
    [Abstract] [Full Text] [Related]

  • 19. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y, Zhang L, Li P, Cui X, Chen L, He S, Shen A.
    Exp Mol Pathol; 2009 Dec 01; 87(3):167-72. PubMed ID: 19686732
    [Abstract] [Full Text] [Related]

  • 20. Step classification is useful for the determination of indications for systematized hepatectomy in hepatocellular carcinoma.
    Ariizumi S, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K.
    J Hepatobiliary Pancreat Surg; 2005 Dec 01; 12(5):371-7. PubMed ID: 16258805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.